Premium
Systematic review with meta‐analysis: the long‐term efficacy of Barrett's endoscopic therapy—stringent selection criteria and a proposal for definitions
Author(s) -
Desai Madhav,
Rösch Thomas,
Sundaram Suneha,
Chandrasekar Viveksandeep Thoguluva,
Kohli Divyanshoo,
Spadaccini Marco,
Hassan Cesare,
Repici Alessandro,
Sharma Prateek
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16473
Subject(s) - medicine , dysplasia , barrett's oesophagus , meta analysis , intestinal metaplasia , barrett's esophagus , gastroenterology , adenocarcinoma , surgery , cancer
Summary Background Barrett's endoscopic therapy (BET) is well established for neoplasia in Barrett's oesophagus using a concept of complete eradication of all Barrett's. However, long‐term efficacy is not known. Aims To perform a systematic review and meta‐analysis to examine long‐term efficacy of BET for Barrett's neoplasia. Methods Electronic databases were searched for studies meeting stringent criteria: (a) subjects with high‐grade dysplasia and/or superficial adenocarcinoma who underwent BET (ablation ± endoscopic mucosal resection); (b) BET completion by confirmation of complete eradication of neoplasia (CE‐N) and intestinal metaplasia (CE‐IM) with systematic sampling and (c) clearly defined follow‐up (endoscopy and biopsy) protocol of ≥2 years thereafter for detection of recurrence. Pooled estimates of CE‐N and CE‐IM after BET completion and follow‐up were analysed. Results Eight studies met the stringent criteria (n = 794, males 89%, age 64.6 years). Despite high efficacy of BET at therapy completion (CE‐N: 95.9 [91.7‐98.7]%; CE‐IM: 90.9 [83‐96.6]%), this declined (CE‐N: 89 [73.4‐98.2]%; CE‐IM: 77.8 [65.6‐88]%) over 3.4 years of follow‐up. There was considerable heterogeneity. Only two studies reported a post‐BET follow‐up of >5 years (CE‐IM 50 [41.5%‐58.5]%). Higher person years of follow‐up seem to correlate with decrease in BET efficacy. Conclusion Using stringent criteria for appropriate study selection with sufficient follow‐up, a lack of high‐quality controlled intervention trials becomes evident for assessment of long‐term durable remission rates of BET despite initial high success rates. We plea for a uniform documentation of study details which could be used in future trials.